BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11377026)

  • 1. Validation of an AAS method for the determination of platinum in biological fluids from patients receiving the oral platinum derivative JM216.
    Vouillamoz-Lorenz S; Bauer J; Lejeune F; Decosterd LA
    J Pharm Biomed Anal; 2001 Jun; 25(3-4):465-75. PubMed ID: 11377026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of satraplatin (JM216), an oral platinum (IV) complex under daily oral administration for 5 or 14 days.
    Vouillamoz-Lorenz S; Buclin T; Lejeune F; Bauer J; Leyvraz S; Decosterd LA
    Anticancer Res; 2003; 23(3C):2757-65. PubMed ID: 12926110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biotransformation of the platinum drug JM216 following oral administration to cancer patients.
    Raynaud FI; Mistry P; Donaghue A; Poon GK; Kelland LR; Barnard CF; Murrer BA; Harrap KR
    Cancer Chemother Pharmacol; 1996; 38(2):155-62. PubMed ID: 8616906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of total platinum in plasma and plasma ultrafiltrate, from subjects dosed with the platinum-containing N-(2-hydroxypropyl)methacrylamide copolymer AP5280, by use of graphite-furnace Zeeman atomic-absorption spectrometry.
    Tibben MM; Rademaker-Lakhai JM; Rice JR; Stewart DR; Schellens JH; Beijnen JH
    Anal Bioanal Chem; 2002 Jul; 373(4-5):233-6. PubMed ID: 12110973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of platinum complexes in clinical samples by a rapid flameless atomic absorption spectrometry assay.
    Kloft C; Appelius H; Siegert W; Schunack W; Jaehde U
    Ther Drug Monit; 1999 Dec; 21(6):631-7. PubMed ID: 10604824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of oxaliplatin in human plasma and plasma ultrafiltrate by graphite-furnace atomic-absorption spectrometry.
    Brouwers EE; Tibben MM; Joerger M; van Tellingen O; Rosing H; Schellens JH; Beijnen JH
    Anal Bioanal Chem; 2005 Aug; 382(7):1484-90. PubMed ID: 15952001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of a highly sensitive ICP-MS method for the determination of platinum in biofluids: application to clinical pharmacokinetic studies with oxaliplatin.
    Morrison JG; White P; McDougall S; Firth JW; Woolfrey SG; Graham MA; Greenslade D
    J Pharm Biomed Anal; 2000 Dec; 24(1):1-10. PubMed ID: 11108533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitive inductively coupled plasma mass spectrometry assay for the determination of platinum originating from cisplatin, carboplatin, and oxaliplatin in human plasma ultrafiltrate.
    Brouwers EE; Tibben MM; Rosing H; Hillebrand MJ; Joerger M; Schellens JH; Beijnen JH
    J Mass Spectrom; 2006 Sep; 41(9):1186-94. PubMed ID: 16929560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of enloplatin by liquid chromatography and of platinum by atomic absorption spectrometry in various biological fluids.
    Amorusi P; Lessard D; Bansal SK; Selinger K; Yacobi A; Tonelli AP
    J Pharm Biomed Anal; 1994 Aug; 12(8):1023-33. PubMed ID: 7819376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic and pharmacodynamic analysis of bis-acetato-ammine-dichloro-cyclohexylamine-platinum(IV) (JM216) administered once a day for five consecutive days: a phase I study.
    Kurata T; Tamura T; Sasaki Y; Fujii H; Negoro S; Fukuoka M; Saijo N
    Jpn J Clin Oncol; 2000 Sep; 30(9):377-84. PubMed ID: 11095134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of an HPLC method for the determination of urinary and plasma levels of N1-methylnicotinamide, an endogenous marker of renal cationic transport and plasma flow.
    Musfeld C; Biollaz J; BĂ©laz N; Kesselring UW; Decosterd LA
    J Pharm Biomed Anal; 2001 Jan; 24(3):391-404. PubMed ID: 11199218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of oxaliplatin (NSC 266046) alone and in combination with paclitaxel in cancer patients.
    Liu J; Kraut E; Bender J; Brooks R; Balcerzak S; Grever M; Stanley H; D'Ambrosio S; Gibson-D'Ambrosio R; Chan KK
    Cancer Chemother Pharmacol; 2002 May; 49(5):367-74. PubMed ID: 11976830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A validated liquid chromatography/tandem mass spectrometry assay for cis-amminedichloro(2-methylpyridine)platinum(II) in human plasma ultrafiltrate.
    Oe T; Tian Y; O'Dwyer PJ; Roberts DW; Malone MD; Bailey CJ; Blair IA
    Anal Chem; 2002 Feb; 74(3):591-9. PubMed ID: 11838680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Speciation of platinum in blood plasma and urine by micelle-mediated extraction and graphite furnace atomic absorption spectrometry.
    Mortada WI; Hassanien MM; El-Asmy AA
    J Trace Elem Med Biol; 2013 Oct; 27(4):267-72. PubMed ID: 23669311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular metabolism of the orally active platinum drug JM216: influence of glutathione levels.
    Raynaud FI; Odell DE; Kelland LR
    Br J Cancer; 1996 Aug; 74(3):380-6. PubMed ID: 8695352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of platinum in workroom air and in blood and urine from nursing staff attending patients receiving cisplatin chemotherapy.
    Nygren O; Lundgren C
    Int Arch Occup Environ Health; 1997; 70(3):209-14. PubMed ID: 9298405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification and clinical application of carboplatin in plasma ultrafiltrate.
    Downing K; Jensen BP; Grant S; Strother M; George P
    J Pharm Biomed Anal; 2017 May; 138():373-377. PubMed ID: 28260690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I and pharmacokinetic study of an oral platinum complex given daily for 5 days in patients with cancer.
    McKeage MJ; Raynaud F; Ward J; Berry C; O'Dell D; Kelland LR; Murrer B; Santabárabara P; Harrap KR; Judson IR
    J Clin Oncol; 1997 Jul; 15(7):2691-700. PubMed ID: 9215842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A validated inductively coupled plasma mass spectrometry (ICP-MS) method for the quantification of total platinum content in plasma, plasma ultrafiltrate, urine and peritoneal fluid.
    Lemoine L; Thijssen E; Noben JP; Adriaensens P; Carleer R; Speeten KV
    J Pharm Biomed Anal; 2018 Apr; 152():39-46. PubMed ID: 29414017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct analysis of platinum in plasma and urine by electrothermal atomic absorption spectrophotometry.
    Hopfer SM; Ziebka L; Sunderman FW; Sporn JR; Greenberg BR
    Ann Clin Lab Sci; 1989; 19(6):389-96. PubMed ID: 2690729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.